🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for transformative discoveries that clarify how the immune system targets dangerous pathogens while sparing the healthy tissues.

A trio of renowned researchers—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this honor.

Their work uncovered specialized "sentinels" within the immune system that remove malfunctioning defense cells that could harming the organism.

The discoveries are now paving the way for new treatments for autoimmune diseases and malignancies.

The laureates will divide a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"Their work has been decisive for understanding how the body's defenses functions and the reason we don't all develop severe autoimmune diseases," commented the chair of the Nobel Committee.

This team's research address a fundamental mystery: How does the immune system defend us from numerous infections while keeping our own tissues unharmed?

The immune system employs immune cells that search for indicators of infection, even viruses and bacteria it has never encountered.

Such defenders employ sensors—known as receptors—that are generated by chance in countless combinations.

This provides the defense network the capacity to combat a broad range of invaders, but the unpredictability of the process inevitably creates white blood cells that may target the host.

Security Guards of the Immune System

Scientists previously understood that a portion of these problematic white blood cells were eliminated in the immune organ—where immune cells develop.

The latest award recognizes the discovery of T-reg cells—known as the immune system's "peacekeepers"—which patrol the system to disarm any defenders that assault the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel added, "The findings have laid the foundation for a new field of research and accelerated the creation of new therapies, for instance for cancer and autoimmune diseases."

Regarding cancer, T-regs block the system from fighting the tumor, so research are aimed at lowering their quantity.

For self-attack disorders, experiments are testing increasing regulatory T-cells so the body is not being harmed. A comparable method could also be effective in reducing the chances of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, from a Japanese institution, performed experiments on rodents that had their thymus removed, leading to autoimmune disease.

The researcher showed that injecting defense cells from other animals could prevent the disease—suggesting there was a system for preventing defenders from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in mice and humans that led to the discovery of a gene critical for how regulatory T-cells function.

"The pioneering work has revealed how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a leading biological science expert.

"This work is a striking illustration of how fundamental biological research can have far-reaching implications for human health."